NeuroPace Inc

NASDAQ:NPCE  
10.04
+0.03 (+0.30%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)241.43M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$10.12 Million
Adjusted EPS-$0.34
See more estimates
10-Day MA$10.89
50-Day MA$14.68
200-Day MAN/A
See more pivots

NeuroPace Inc Stock, NASDAQ:NPCE

455 North Bernardo Avenue, Mountain View, California 94043
United States of America
Phone: +1.650.237.2700
Number of Employees: 152

Description

NeuroPace, Inc. develops, manufactures and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's product RNS system is designed for the treatment of medically refractory partial epilepsy includes implantable and external products. The company was founded by Robert Fischell, David Fischell, Tim Fischell, Scott Fischell, Rebecca L. Kuhn, Frank M. Fischer and Martha Morrell on November 19, 1997 and is headquartered in Mountain View, CA.